Monthly Archives: March 2022
Effect of combining aspirin and rivaroxaban on atherosclerosis in mice.
Grover SP, Coughlin T, Fleifil SM, Posma JJN, Spronk HHM, Heitmeier S, Owens AP 3rd, Mackman N. Atherosclerosis. 2022 Mar;345:7-14. PMID: 35183904 Background and aims: The platelet inhibitor aspirin reduces inflammation and atherosclerosis in both apolipoprotein E deficient (apoE-/-) mice … Continue reading
Posted in publications, research
Leave a comment
Variation of platelet function in clinical phenotypes of acute venous thromboembolism – Results from the GMP-VTE project
Marina Panova-Noeva, Bianca Wagner, Markus Nagler, Thomas Koeck, Vincent Ten Cate, Lisa Eggebrecht, Jürgen H Prochaska, Imke Meyer, Christoph Gerdes, Henri M Spronk, Karl J Lackner, Hugo Ten Cate, Kirsten Leineweber, Stefan Heitmeier, Stavros Konstantinides, Philipp S Wild J Thromb … Continue reading
Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow.
Brouns SLN, Tullemans BME, Bulato C, Perrella G, Campello E, Spiezia L, van Geffen JP, Kuijpers MJE, van Oerle R, Spronk HMH, van der Meijden PEJ, Simioni P, Heemskerk JWM. Res Pract Thromb Haemost. 2022 Mar 7;6(2):e12678. PMID: 35284776 Background: … Continue reading
Posted in publications, research
Leave a comment